Holley Group
VC Fund
Hangzhou, China
Holley Group is a VC fund in Hangzhou focused on Medical and Biotechnology. Holley Group manufactures pharmaceutical products. Holley mainly researches, develops, produces, and sells biological and chemical pharmaceuticals, herbal pharmaceuticals, health-care products, and traditional Chinese medicines. The company also operates in real estate development and instrumentation manufacturing.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Holley Group invests in
Stages Holley Group invests in
Countries Holley Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hong Luo
|
|||
|
Qijing Xiao
|
|||
Investment Focus
Industry
- Medical 2 (40%)
- Biotechnology 2 (40%)
- Sales 1 (20%)
- FinTech 1 (20%)
- Payments 1 (20%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Angel 1 (20%)
- Series B 1 (20%)
Country
- China 4 (80%)
- United States 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hong Luo
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Qijing Xiao
Chief Executive Officer and President
|
Chief Executive Officer and President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs.The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantationand creating the organ factory of the future.ClonOrgas was established in 2005 in Chengdu, Sichuan. | Series A / Aug 07, 2026 | |
|
|
Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines. | $29.7M / Series A / Aug 10, 2022 | |
|
|
Detu focuses on creating consumer and professional 360 cameras and accessories that allow users to capture life as it happens around them. Its love of innovation and creativity drives the company to constantly improve and refine its products, ensuring that they provide the best possible experience. Detu has the tools customers need to createstunning, immersive content, whether they are a professional photographer or simply someone who enjoys capturing memories. | Series B / Aug 16, 2017 | |
|
|
Everex develops an adaptive crypto-secured credit card and hybrid crypto/payment processing for the Web3 economy. We have pioneered the application of Stablecoins for real-time settlements for a variety of use cases, including credit merchant settlements, cross-border transfers, and global credit building. Everex is a strong advocate offinancial inclusion and equal access to capital in developing markets, including financial applications for Islamic banking. | Seed / Jul 24, 2017 | |
|
|
HOUDAR is a company for R&D, production, sales and service of robotics products. | Angel / Dec 14, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Holley Group invest in?
Holley Group invests primarily in Medical, Biotechnology and Sales startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Holley Group?
Public channels for Holley Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Holley Group?
The team at Holley Group includes Hong Luo (Chief Financial Officer) and Qijing Xiao (Chief Executive Officer and President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!